Equity Overview
Price & Market Data
Price: $10.91
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $373,721,056
Daily Volume: 0
Performance Metrics
1 Week: 8.45%
1 Month: -3.79%
3 Months: -8.24%
6 Months: -21.17%
1 Year: -9.23%
YTD: -19.01%
Company Details
Employees: 19
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.